Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oesophageal functional phenotypes in refractory gastro-oesophageal reflux disease-related chronic cough.

ERJ open research·2026
Same author

Risk Factors for COVID-19 mRNA Vaccine-Associated Exacerbations in Patients With Obstructive Airway Diseases: REsearch for Asthma and COPD ExacerbaTION Caused by COVID-19 mRNA Vaccination (REACTION Study).

Allergy, asthma & immunology research·2026
Same author

Characteristic computed tomography features of mild-to-moderate Legionella pneumonia: evaluation of a known pattern and identification of a novel indicator.

BMC pulmonary medicine·2026
Same author

Outcomes following the discontinuation of biologic therapy in patients with severe asthma.

Allergology international : official journal of the Japanese Society of Allergology·2026
Same author

Integrated genetic analyses identified T-cell neoplasms other than adult T-cell leukemia/lymphoma in HTLV-1 carriers.

Blood advances·2025
Same author

[COMPREHENSIVE APPROACH TO CHRONIC ALLERGIC/INFLAMMATORY AIRWAY DISEASES].

Arerugi = [Allergy]·2025

Related Experiment Video

Updated: May 18, 2026

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

Angioimmunoblastic T-cell lymphoma mice model.

Fumihiko Sato1, Takashi Ishida, Asahi Ito

  • 1Department of Medical Oncology and Immunology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi 467-8601, Japan.

Leukemia Research
|October 3, 2012
PubMed
Summary

Researchers developed a new mouse model for angioimmunoblastic T-cell lymphoma (AITL). This model mimics human AITL, showing that AITL cells may originate from follicular helper T (TFH) cells and support antibody production.

More Related Videos

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

Using the BLT Humanized Mouse as a Stem Cell based Gene Therapy Tumor Model
06:59

Using the BLT Humanized Mouse as a Stem Cell based Gene Therapy Tumor Model

Published on: December 18, 2012

Related Experiment Videos

Last Updated: May 18, 2026

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

Using the BLT Humanized Mouse as a Stem Cell based Gene Therapy Tumor Model
06:59

Using the BLT Humanized Mouse as a Stem Cell based Gene Therapy Tumor Model

Published on: December 18, 2012

Area of Science:

  • Immunology
  • Oncology
  • Hematology

Background:

  • Angioimmunoblastic T-cell lymphoma (AITL) is an aggressive non-Hodgkin lymphoma.
  • The cell of origin for AITL remains debated, with follicular helper T (TFH) cells being a leading hypothesis.
  • A lack of suitable experimental models has hindered research into AITL pathogenesis.

Purpose of the Study:

  • To establish a functional mouse model for AITL.
  • To investigate the role of TFH cells in AITL development.
  • To explore the interaction between AITL cells and B cells/plasma cells.

Main Methods:

  • Generation of an AITL mouse model using NOD/Shi-scid, IL-2Rγ(null) recipient mice.
  • Immunohistological analysis of tumor tissues from AITL mice.
  • Detection of human immunoglobulins (IgG, IgA, IgM) in mouse sera.

Main Results:

  • The established AITL mouse model exhibited immunohistological features nearly identical to human AITL.
  • Significant levels of human IgG, IgA, and IgM were detected in the sera of AITL mice.
  • These findings suggest AITL tumor cells contribute to antibody production by B cells or plasma cells.

Conclusions:

  • This study successfully established a relevant experimental model for AITL research.
  • The model supports the hypothesis that AITL originates from TFH cells.
  • The model demonstrates the functional capacity of AITL cells to influence antibody production.